| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.008 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.008 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |